Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Niagen Bioscience launched its first ready-to-inject liquid Niagen At-Home Injection Kit through the Niagen Plus telehealth platform, a clinician-directed, prescription-only product dispensed via state-licensed 503A compounding pharmacies. The launch is backed by two open-label pilot studies (n=39) on medRxiv showing sub-q and IM injectable Niagen was well tolerated over 90 days of at-home use, with exploratory improvements in fatigue, sleep, and skin health that require placebo-controlled confirmation.
Key figures
- Vial size ml
- 5
- Niagen per vial mg
- 500
- Pilot study participants
- 39
- At home self injection duration days
- 90
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.